Location History:
- Ridgewood, NJ (US) (1992 - 1993)
- Boston, MA (US) (1994 - 1997)
Company Filing History:
8 out of 25 
1 out of 349 
Years Active: 1992-1997
Title: The Innovative Contributions of Tsuneya Ohno
Introduction
Tsuneya Ohno is a prominent inventor based in Boston, MA, known for his significant contributions to the field of immunotherapy. With a total of nine patents to his name, he has made remarkable strides in the development of treatments for various diseases, particularly HIV.
Latest Patents
One of his latest patents focuses on HIV immunotherapeutics, specifically the NM03 antibody materials and methods. This invention provides a monoclonal antibody, designated NM03, which specifically binds to HIV-1 gp120. This innovative approach has the potential to enhance the effectiveness of treatments for individuals affected by HIV.
Career Highlights
Throughout his career, Tsuneya Ohno has worked with notable companies, including Nissin Shokuhin Kabushiki Kaisha and Arch Development Corporation. His experience in these organizations has contributed to his expertise in the field of biotechnology and immunotherapy.
Collaborations
Tsuneya has collaborated with esteemed colleagues such as Masaki Terada and Ralph R. Weichselbaum. These partnerships have fostered a collaborative environment that encourages innovation and the advancement of medical research.
Conclusion
Tsuneya Ohno's work in the field of immunotherapy, particularly his developments related to HIV treatment, showcases his dedication to improving healthcare outcomes. His contributions continue to influence the landscape of medical research and innovation.